Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach
- 12 December 2001
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 16 (8) , 579-588
- https://doi.org/10.1002/hup.347
Abstract
Human users of 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) users may be at risk of developing MDMA‐induced neuronal injury. Previously, no methods were available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivo neuroimaging tools has begun to provide insights into the effects of MDMA in the human brain. In this review, contributions of brain imaging studies on the potential neurotoxic effects of MDMA and functional consequences are highlighted. An overview is given of PET, SPECT and MR spectroscopy studies, most of which show evidence of neuronal injury in MDMA users. Different neuroimaging tools are discussed that have investigated potential functional consequences of MDMA‐induced 5‐HT neurotoxic lesions. Finally, the contribution of brain imaging in future studies is discussed, emphasising the crucial role it will play in our understanding of MDMA's short‐ and long‐term effects in the human brain. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 54 references indexed in Scilit:
- Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PETNuclear Medicine Communications, 2001
- 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy HumansNeuropsychopharmacology, 2000
- 5-HT system and cognitionNeuroscience & Biobehavioral Reviews, 1999
- CorrespondenceNeuropsychopharmacology, 1999
- Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4-methyl-4-piperidinyl]-5-IODO-2-methoxybenzamide as a potential 5HT2 receptor tracer for SPE(C)TNuclear Medicine and Biology, 1995
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- Selective dopamine transporter inhibition by cocaine analogsNeuroReport, 1992
- Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptorsNeuropharmacology, 1992
- Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationBrain Research, 1988
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987